LDOS
Leidos Holdings, Inc. NYSE Listed Oct 17, 2006$131.22
Mkt Cap $16.5B
52w Low $129.36
2.4% of range
52w High $205.77
50d MA $160.35
200d MA $178.69
P/E (TTM)
13.3x
EV/EBITDA
12.1x
P/B
4.0x
Debt/Equity
1.2x
ROE
29.4%
P/FCF
14.9x
RSI (14)
—
ATR (14)
—
Beta
0.66
50d MA
$160.35
200d MA
$178.69
Avg Volume
1.1M
Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, the Department of Defense, the National Aeronautics and Space Administration, military services, and government agencies of U.S. allies abroad, as well as other federal and commercial customers in the national security industry. Its solutions include technology, large-scale systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to air navigation service providers, including the federal aviation administration, the En route automation modernization, advanced technology oceanic procedure, time based flow management, terminal flight data management, geo-7, and future flight services, as well as enterprise-information display systems; and security detection and automation services. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; and environment, energy, and infrastructure services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including health information management, managed health, digital transformation, and life sciences research and development services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.
1750 Presidents Street · Reston, VA 20190 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 2.88 | 3.13 | +8.7% | 137.19 | -0.9% | -1.7% | -4.3% | — | — | — | — |
| Feb 17, 2026 | TNS | 2.61 | 2.76 | +5.7% | 161.53 | +1.2% | +6.2% | +6.2% | +9.1% | +7.4% | +6.5% | — |
| Nov 4, 2025 | TNS | 2.71 | 3.05 | +12.5% | 199.55 | +0.2% | -2.2% | -2.2% | -2.4% | -1.3% | -1.3% | — |
| Aug 5, 2025 | TNS | 2.66 | 3.21 | +20.7% | 172.94 | +1.2% | +0.9% | +0.9% | +1.3% | +2.1% | +2.4% | — |
| May 6, 2025 | TNS | 2.50 | 2.97 | +18.8% | 154.75 | -0.6% | -0.0% | -0.0% | -0.0% | +0.6% | +0.9% | — |
| Feb 11, 2025 | TNS | 2.24 | 2.37 | +5.8% | 137.60 | -0.8% | -0.5% | -0.5% | -5.1% | -3.9% | -4.6% | — |
| Oct 29, 2024 | TNS | 2.02 | 2.93 | +45.0% | 185.86 | +1.2% | -0.1% | -0.1% | -1.5% | -1.6% | +0.2% | — |
| Jul 30, 2024 | TNS | 2.27 | 2.63 | +15.9% | 145.98 | +1.4% | -1.1% | -1.1% | -0.8% | -0.4% | -2.3% | — |
| Apr 30, 2024 | TNS | 1.70 | 2.29 | +34.7% | 140.22 | -0.4% | +1.4% | +1.4% | +1.7% | +1.0% | +1.7% | — |
| Feb 13, 2024 | TNS | 1.74 | 1.99 | +14.4% | 121.28 | +0.5% | +0.2% | +0.2% | +0.8% | +2.1% | +1.8% | — |
| Oct 31, 2023 | TNS | 1.64 | 2.03 | +23.8% | 99.12 | +0.9% | +2.1% | +2.1% | +4.1% | +4.9% | +4.2% | — |
| Aug 1, 2023 | TNS | 1.57 | 1.80 | +14.6% | 99.98 | +0.0% | -1.4% | -1.4% | -1.6% | -2.9% | -2.4% | — |
| May 2, 2023 | BMO | 1.59 | 1.47 | -7.5% | 80.61 | -0.1% | +0.3% | +0.3% | -1.4% | +0.3% | -1.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 | BofA Securities | Maintains | Buy → Buy | — | $154.82 | $153.84 | -0.6% | -1.0% | -2.7% | -4.7% | -5.7% | -6.8% |
| Apr 20 | Truist | Maintains | Buy → Buy | — | $155.17 | $155.73 | +0.4% | -0.2% | -1.3% | -2.9% | -4.9% | -5.9% |
| Feb 18 | Stifel | Maintains | Hold → Hold | — | $161.53 | $163.44 | +1.2% | +6.2% | +9.1% | +7.4% | +6.5% | +7.8% |
| Feb 18 | Baird | Maintains | Neutral → Neutral | — | $161.53 | $163.44 | +1.2% | +6.2% | +9.1% | +7.4% | +6.5% | +7.8% |
| Feb 18 | RBC Capital | Maintains | Outperform → Outperform | — | $161.53 | $163.44 | +1.2% | +6.2% | +9.1% | +7.4% | +6.5% | +7.8% |
| Jan 15 | UBS | Maintains | Neutral → Neutral | — | $190.82 | $190.39 | -0.2% | +1.3% | +2.0% | +0.1% | +0.7% | +1.4% |
| Jan 13 | Citigroup | Maintains | Buy → Buy | — | $195.60 | $196.77 | +0.6% | +0.2% | -2.4% | -1.1% | -0.5% | -2.4% |
| Jan 8 | Stifel | Downgrade | Buy → Hold | — | $196.61 | $198.00 | +0.7% | -0.7% | +0.9% | -0.5% | -0.3% | -2.9% |
| Nov 7 | BofA Securities | Maintains | Buy → Buy | — | $194.76 | $195.13 | +0.2% | +1.1% | +1.1% | +1.8% | -0.9% | -1.8% |
| Nov 5 | Truist | Maintains | Buy → Buy | — | $199.55 | $199.98 | +0.2% | -2.2% | -2.4% | -1.3% | -1.3% | -0.7% |
| Nov 5 | UBS | Maintains | Neutral → Neutral | — | $199.55 | $199.98 | +0.2% | -2.2% | -2.4% | -1.3% | -1.3% | -0.7% |
| Oct 31 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $190.92 | $191.01 | +0.0% | -0.2% | +1.1% | +4.5% | +2.2% | +2.0% |
| Sep 24 | Argus | Maintains | Buy → Buy | — | $187.11 | $188.33 | +0.7% | +0.2% | -2.5% | -1.2% | -0.8% | +1.0% |
| Sep 4 | RBC Capital | Upgrade | Sector Perform → Outperform | — | $177.71 | $177.00 | -0.4% | +0.5% | +0.7% | +0.4% | +0.7% | +1.5% |
| Sep 4 | BofA Securities | Maintains | Buy → Buy | — | $177.71 | $177.00 | -0.4% | +0.5% | +0.7% | +0.4% | +0.7% | +1.5% |
| Aug 7 | UBS | Maintains | Neutral → Neutral | — | $174.49 | $175.48 | +0.6% | +0.4% | +1.2% | +1.5% | +2.0% | +4.3% |
| Aug 6 | Jefferies | Upgrade | Hold → Buy | — | $172.94 | $175.00 | +1.2% | +0.9% | +1.3% | +2.1% | +2.4% | +2.9% |
| Jul 14 | Citigroup | Maintains | Buy → Buy | — | $162.05 | $161.81 | -0.1% | +1.0% | -1.1% | -0.6% | +0.4% | +0.3% |
| May 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $154.72 | $155.99 | +0.8% | -0.0% | +0.6% | +0.9% | +0.5% | -1.1% |
| May 7 | UBS | Maintains | Neutral → Neutral | — | $154.75 | $153.88 | -0.6% | -0.0% | -0.0% | +0.6% | +0.9% | +0.4% |
| May 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $154.75 | $153.88 | -0.6% | -0.0% | -0.0% | +0.6% | +0.9% | +0.4% |
| Apr 14 | Truist | Maintains | Buy → Buy | — | $141.88 | $143.20 | +0.9% | +0.8% | -0.3% | -1.4% | -1.7% | -2.6% |
| Apr 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $132.90 | $135.00 | +1.6% | +0.3% | +5.1% | +5.1% | +6.8% | +7.6% |
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $130.74 | $129.95 | -0.6% | -0.9% | -0.8% | -0.6% | -1.2% | +1.1% |
| Feb 21 | William Blair | Downgrade | Outperform → Market Perform | — | $130.05 | $129.16 | -0.7% | -2.5% | -1.3% | +0.5% | -0.4% | -0.3% |
| Feb 12 | Truist | Maintains | Buy → Buy | — | $137.60 | $136.48 | -0.8% | -0.5% | -5.1% | -3.9% | -4.6% | -4.4% |
| Feb 12 | UBS | Maintains | Neutral → Neutral | — | $137.60 | $136.48 | -0.8% | -0.5% | -5.1% | -3.9% | -4.6% | -4.4% |
| Feb 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $137.60 | $136.48 | -0.8% | -0.5% | -5.1% | -3.9% | -4.6% | -4.4% |
| Jan 8 | TD Cowen | Downgrade | Buy → Hold | — | $147.30 | $146.61 | -0.5% | -1.1% | +1.5% | +3.6% | +3.7% | +5.4% |
| Jan 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $147.30 | $146.61 | -0.5% | -1.1% | +1.5% | +3.6% | +3.7% | +5.4% |
| Dec 12 | Goldman Sachs | Downgrade | Buy → Neutral | — | $153.55 | $150.10 | -2.2% | -0.4% | -0.3% | -0.7% | -2.2% | -4.9% |
| Nov 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $163.60 | $163.59 | -0.0% | +1.5% | +0.2% | +1.1% | +0.3% | +0.3% |
| Nov 22 | Truist | Maintains | Buy → Buy | — | $164.69 | $165.37 | +0.4% | +0.5% | -0.7% | +0.9% | -0.4% | +0.4% |
| Nov 4 | Barclays | Maintains | Overweight → Overweight | — | $182.97 | $184.35 | +0.8% | +1.8% | +3.9% | +6.1% | +5.3% | +8.4% |
| Oct 30 | Goldman Sachs | Maintains | Buy → Buy | — | $185.86 | $188.12 | +1.2% | -0.1% | -1.5% | -1.6% | +0.2% | +2.3% |
| Oct 30 | TD Cowen | Maintains | Buy → Buy | — | $185.86 | $188.12 | +1.2% | -0.1% | -1.5% | -1.6% | +0.2% | +2.3% |
| Oct 30 | Citigroup | Maintains | Buy → Buy | — | $185.86 | $188.12 | +1.2% | -0.1% | -1.5% | -1.6% | +0.2% | +2.3% |
| Oct 30 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $185.86 | $188.12 | +1.2% | -0.1% | -1.5% | -1.6% | +0.2% | +2.3% |
| Oct 30 | Truist | Maintains | Buy → Buy | — | $185.86 | $188.12 | +1.2% | -0.1% | -1.5% | -1.6% | +0.2% | +2.3% |
| Oct 30 | Baird | Maintains | Outperform → Outperform | — | $185.86 | $188.12 | +1.2% | -0.1% | -1.5% | -1.6% | +0.2% | +2.3% |
| Oct 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $185.86 | $188.12 | +1.2% | -0.1% | -1.5% | -1.6% | +0.2% | +2.3% |
| Oct 10 | Citigroup | Maintains | Buy → Buy | — | $167.67 | $167.43 | -0.1% | -1.9% | -0.3% | +0.6% | +0.0% | +0.2% |
| Oct 2 | JP Morgan | Maintains | Overweight → Overweight | — | $165.01 | $164.50 | -0.3% | +0.1% | +0.1% | +0.8% | +1.0% | +1.0% |
| Oct 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $163.00 | $162.84 | -0.1% | +1.2% | +1.3% | +1.3% | +2.1% | +2.2% |
| Sep 5 | Truist | Maintains | Buy → Buy | — | $156.09 | $156.09 | +0.0% | -0.2% | -2.1% | -1.7% | -1.3% | -2.3% |
| Aug 7 | BofA Securities | Maintains | Buy → Buy | — | $143.29 | $143.96 | +0.5% | -0.1% | +0.8% | +0.6% | +1.0% | +1.1% |
| Aug 5 | Barclays | Maintains | Overweight → Overweight | — | $145.39 | $143.36 | -1.4% | -1.9% | -1.4% | -1.5% | -0.7% | -0.8% |
| Aug 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $144.40 | $145.23 | +0.6% | +0.2% | +0.7% | -1.2% | -0.8% | -0.8% |
| Jul 31 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $145.98 | $148.00 | +1.4% | -1.1% | -0.8% | -0.4% | -2.3% | -1.8% |
| Jul 31 | TD Cowen | Maintains | Buy → Buy | — | $145.98 | $148.00 | +1.4% | -1.1% | -0.8% | -0.4% | -2.3% | -1.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | May Gary StephenDir | — | Sell | 1,484 | $132.75 | $197K | 10,137 | — | — |
8-K · 2.02
!! High
Leidos Holdings, Inc. -- 8-K 2.02: Earnings Results
Leidos Holdings reported Q1 fiscal 2026 earnings results, providing investors with updated financial performance metrics and operational insights for the defense contractor.
May 5
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Leidos is executing a significant contribution agreement involving the AHP Entities, which could reshape its asset structure and potentially impact future earnings, cash flow, and strategic direction for shareholders.
Apr 15
8-K · 2.01
!!! Very High
Unknown — 8-K 2.01: Acquisition Completed
LDOS completed its acquisition of ENTRUST Solutions Group, expanding its government services capabilities and revenue base, which should improve earnings growth and justify higher valuation multiples.
Mar 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The executive leadership change at these defense contractors could signal strategic shifts in operations or capital allocation, so investors should monitor whether the new leader's background and priorities align with their investment thesis.
Mar 25
8-K · 1.01
! Medium
Leidos Holdings, Inc. -- 8-K 1.01: Underwriting / Securities
Leidos Holdings secured a $600 million agreement with a guarantor, strengthening its financial position and liquidity for operations and strategic initiatives.
Mar 3
8-K · 5.02
!!! Very High
Science Applications International Corporation -- 8-K 5.02: Executive Change
Science Applications International Corporation appointed James C. Reagan as CEO effective February 17, 2026, replacing the departing chief executive in a leadership transition at the defense contractor.
Feb 17
8-K · 1.01
!! High
Leidos Holdings, Inc. -- 8-K 1.01: Material Agreement
Leidos Holdings amended and restated a material agreement, though specific terms and financial impact remain undisclosed in this filing notice.
Feb 17
8-K · 7.01
! Medium
Leidos Holdings, Inc. -- 8-K 7.01: Regulation FD Disclosure
Leidos Holdings restructured operations into four reportable segments effective January 2026, requiring investors to reassess divisional performance metrics and track segment-specific profitability going forward.
Feb 17
Data updated apr 25, 2026 6:44pm
· Source: massive.com